- Home
- / Valo Therapeutics
Valo Therapeutics
Total Funding
$1.1 M
Valo Therapeutics Summary
Company Summary
- Overview
- Valo Therapeutics (ValoTx) is a biotechnology company that develops novel immunotherapies for cancer, oncology, and infectious diseases. It offers Peptide-coated Conditionally Replicating Adenovirus (PeptiCRAd) technology that delivers antigens and peptides through surface coatings.
- Type
- Private
- Status
- Active
- Founded
- 2016
- HQ
- Helsinki, FI | view all locations
- Website
- https://www.valotx.com
- Cybersecurity rating
- Sectors
Table of Contents
Key People
Petri Priha, VP of CMC
Matthew Vaughan, Business Operations Director
Charlotta Backman, VP, Clinical Operations and Regulatory Affairs
Operating MetricsView all
Trademark Applications
3
Jun, 2023
Trademarks
3
Jun, 2023
LocationsView all
1 location detected
Helsinki HQ
Finland
Viikinkaari 6